Do you want to read an article? Please log in or register.
Phase 2 study of dabrafenib plus trametinib in patients with BRAF V600E-mutant metastatic non-small cell lung cancer: Updated 5-year survival rates and genomic analysis
Lung, Respiratory and Thoracic Cancer